Skip to main content

Find Clinical Trials

Home
Conditions
Triple Negative Breast Neoplasms

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Not Yet Recruiting

Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment

NCT06497322

Conditions: Behavior, Breast Cancer, Breast Diseases, +8 more
Locations: University Hospital of Cologne and St. Elizabeth Hospital Cologne, North Rhine-Westphalia, Germany

View Trial Details

Not Yet Recruiting

Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy

NCT06418139

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer

NCT06407310

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer

NCT06404736

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +7 more
Locations: Zhimin Shao Shanghai, Not US/Canada, China

View Trial Details

Not Yet Recruiting

Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab

NCT06371807

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
Locations: Fundaçao Champalimaud, Avenida Brasilia, Lisbon, Portugal

Centro Hospitalar Universitário Lisboa Norte E.P.E Lisbon, Portugal

Instituto Português de Oncologia Francisco Gentil, E.P.E Porto, Portugal

View Trial Details

Not Yet Recruiting

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

NCT06229067

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer

NCT06202313

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Shengjing Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Not Yet Recruiting

T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients

NCT05953168

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer

NCT05843292

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

NCT05698238

Conditions: Adenoma, Breast Diseases, Breast Neoplasms, +25 more
Locations: Not specified

View Trial Details